GH Research PLC (NASDAQ:GHRS) Short Interest Update

GH Research PLC (NASDAQ:GHRS) was the recipient of a large increase in short interest in February. As of February 15th, there was short interest totalling 2,870,000 shares, an increase of 21.1% from the January 31st total of 2,370,000 shares. Approximately 7.9% of the shares of the company are short sold. Based on an average daily volume of 404,900 shares, the days-to-cover ratio is currently 7.1 days.

Analyst Upgrades and Downgrades

GHRS has been the topic of several analyst reports. Cantor Fitzgerald initiated coverage on shares of GH Research in a research report on Thursday, February 13th. They set an “overweight” rating and a $14.00 price target on the stock. Stifel Nicolaus boosted their price objective on GH Research from $18.00 to $32.00 and gave the stock a “buy” rating in a research note on Thursday, February 27th. HC Wainwright reissued a “buy” rating and issued a $40.00 price target on shares of GH Research in a research note on Monday, January 27th. Finally, Canaccord Genuity Group dropped their price objective on shares of GH Research from $31.00 to $28.00 and set a “buy” rating for the company in a report on Monday, November 18th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $30.60.

Hedge Funds Weigh In On GH Research

Hedge funds have recently made changes to their positions in the stock. BNP Paribas Financial Markets acquired a new stake in GH Research in the 4th quarter valued at $44,000. Two Sigma Investments LP purchased a new stake in GH Research during the 4th quarter worth $117,000. Millennium Management LLC purchased a new stake in GH Research during the 4th quarter worth $145,000. AdvisorShares Investments LLC lifted its holdings in GH Research by 15.4% in the 4th quarter. AdvisorShares Investments LLC now owns 36,011 shares of the company’s stock worth $252,000 after buying an additional 4,806 shares in the last quarter. Finally, Northern Trust Corp boosted its position in GH Research by 26.8% in the 4th quarter. Northern Trust Corp now owns 40,834 shares of the company’s stock valued at $286,000 after buying an additional 8,641 shares during the last quarter. Institutional investors and hedge funds own 56.90% of the company’s stock.

GH Research Stock Up 1.3 %

GHRS stock traded up $0.14 during trading on Thursday, hitting $10.55. The company had a trading volume of 246,517 shares, compared to its average volume of 160,059. The firm has a 50-day moving average price of $10.66 and a 200-day moving average price of $9.19. GH Research has a 1-year low of $6.00 and a 1-year high of $20.50. The firm has a market cap of $548.90 million, a PE ratio of -13.35 and a beta of 0.93.

GH Research (NASDAQ:GHRS) last issued its earnings results on Thursday, February 27th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.06. Sell-side analysts anticipate that GH Research will post -0.8 earnings per share for the current year.

GH Research Company Profile

GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD).